China Pharma (CPHI) Competitors $0.21 -0.01 (-4.59%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.21 +0.01 (+2.88%) As of 02/21/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends CPHI vs. SYBX, GOVX, NRSN, BMRA, EGRX, HCWB, CING, MTVA, CRVO, and PHIOShould you be buying China Pharma stock or one of its competitors? The main competitors of China Pharma include Synlogic (SYBX), GeoVax Labs (GOVX), NeuroSense Therapeutics (NRSN), Biomerica (BMRA), Eagle Pharmaceuticals (EGRX), HCW Biologics (HCWB), Cingulate (CING), MetaVia (MTVA), CervoMed (CRVO), and Phio Pharmaceuticals (PHIO). These companies are all part of the "pharmaceutical products" industry. China Pharma vs. Synlogic GeoVax Labs NeuroSense Therapeutics Biomerica Eagle Pharmaceuticals HCW Biologics Cingulate MetaVia CervoMed Phio Pharmaceuticals China Pharma (NYSE:CPHI) and Synlogic (NASDAQ:SYBX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, community ranking, media sentiment, profitability, dividends, risk and institutional ownership. Does the media prefer CPHI or SYBX? In the previous week, China Pharma had 1 more articles in the media than Synlogic. MarketBeat recorded 1 mentions for China Pharma and 0 mentions for Synlogic. Synlogic's average media sentiment score of 0.00 beat China Pharma's score of -0.21 indicating that Synlogic is being referred to more favorably in the news media. Company Overall Sentiment China Pharma Neutral Synlogic Neutral Which has more volatility & risk, CPHI or SYBX? China Pharma has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Comparatively, Synlogic has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500. Is CPHI or SYBX more profitable? Synlogic has a net margin of 0.00% compared to China Pharma's net margin of -85.56%. China Pharma's return on equity of -63.93% beat Synlogic's return on equity.Company Net Margins Return on Equity Return on Assets China Pharma-85.56% -63.93% -31.42% Synlogic N/A -207.84%-114.81% Does the MarketBeat Community believe in CPHI or SYBX? Synlogic received 331 more outperform votes than China Pharma when rated by MarketBeat users. Likewise, 69.54% of users gave Synlogic an outperform vote while only 0.00% of users gave China Pharma an outperform vote. CompanyUnderperformOutperformChina PharmaOutperform VotesNo VotesUnderperform Votes84100.00% SynlogicOutperform Votes33169.54% Underperform Votes14530.46% Do analysts recommend CPHI or SYBX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score China Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Synlogic 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals and insiders hold more shares of CPHI or SYBX? 63.4% of Synlogic shares are held by institutional investors. 17.3% of China Pharma shares are held by company insiders. Comparatively, 3.0% of Synlogic shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has better valuation & earnings, CPHI or SYBX? China Pharma has higher revenue and earnings than Synlogic. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina Pharma$5.54M0.72-$3.08MN/AN/ASynlogic$3.37M4.81-$57.28M-$4.16-0.33 SummarySynlogic beats China Pharma on 8 of the 14 factors compared between the two stocks. Get China Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CPHI vs. The Competition Export to ExcelMetricChina PharmaPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$4.20M$7.04B$5.77B$20.08BDividend YieldN/A2.87%4.78%3.65%P/E RatioN/A5.7325.8234.36Price / Sales0.72312.55453.6615.65Price / CashN/A67.8344.0520.85Price / Book0.306.747.634.92Net Income-$3.08M$138.11M$3.18B$1.02B7 Day Performance-3.70%-2.54%-1.95%-1.05%1 Month Performance-0.91%-2.00%-0.23%-1.09%1 Year Performance-53.83%-5.04%16.69%13.70% China Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CPHIChina PharmaN/A$0.21-4.6%N/A-58.1%$4.20M$7.01M0.00250Analyst ForecastNews CoverageSYBXSynlogicN/A$1.40flatN/A-29.7%$16.38M$3.37M-0.3480GOVXGeoVax Labs1.7314 of 5 stars$1.73+1.2%$14.20+720.8%-24.9%$16.33M$80,000.000.0010NRSNNeuroSense Therapeutics1.1798 of 5 stars$1.16-1.3%N/A-12.8%$15.78MN/A-1.8010BMRABiomerica0.4744 of 5 stars$0.83+6.7%N/A-22.6%$15.22M$5.41M-2.4460Gap UpEGRXEagle PharmaceuticalsN/A$1.17-0.8%N/A-76.1%$15.20M$316.61M0.00100HCWBHCW Biologics0.2621 of 5 stars$0.40-2.3%N/A-65.5%$15.13M$3.50M-0.4040CINGCingulate2.8593 of 5 stars$4.51+3.9%$16.00+254.8%+300.5%$14.49MN/A0.0020MTVAMetaVia1.6199 of 5 stars$1.67+1.5%$12.00+616.8%N/A$14.43MN/A0.0010Gap UpCRVOCervoMed3.6014 of 5 stars$2.33+6.4%$40.86+1,653.5%-84.3%$14.38M$7.14M0.004Analyst UpgradeNews CoveragePHIOPhio Pharmaceuticals3.3657 of 5 starsN/A$36.00+∞-75.3%$13.98MN/A0.0010Analyst ForecastAnalyst RevisionNews Coverage Related Companies and Tools Related Companies Synlogic Competitors GeoVax Labs Competitors NeuroSense Therapeutics Competitors Biomerica Competitors Eagle Pharmaceuticals Competitors HCW Biologics Competitors Cingulate Competitors MetaVia Competitors CervoMed Competitors Phio Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CPHI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWatch This Robotics Demo Before March 17thJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Pharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
